While we are 100% supportive of the need for safety concerns to be carefully and fully addressed and recognize that PI3Ki have a significant potential downside, we argue when used properly with careful monitoring and aggressive management of adverse events, they offer a proven benefit for CLL patients with
August 14, 2022
BREAKING NEWS
Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Menu
